Cyfendus (anthrax vaccine adsorbed, adjuvanted) is a vaccine indicated for the post-exposure prophylaxis of anthrax disease following suspected or confirmed exposure to Bacillus anthracis in people aged 18 through 65 years of age. It is administered in c
Altered Immunocompetence:Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished immune response to CYFENDUS®vaccine. Pregnancy:CYFENDUS®vaccine can cause fetal harm when administered to a pregnant individual. Before getting CYFENDUS® vaccine, tell ...
(BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and Human Services has awarded a $75 million option to Emergent’s existing contract (HHSO100201600030C) for the acquisition of newly licensed anthrax vaccine CYFENDUS™...